Pen Injectors are mainly used for the subcutaneous delivery of biopharmaceuticals, primarily for self-administration by the patient. The ability to self-inject has been the core driver for their development and made them such an important part of the world of drug delivery devices for more than 25 years. With the world wide increase in diabetes as well as the trend towards biological drugs which cannot be administered orally, pen injectors importance continues to grow.
Pens have continuously been developed to meet the needs of patients in the key areas of diabetes (insulin and glucagon-like peptide), growth hormone and other hormone replacement therapies, hepatitis C, multiple sclerosis, cancer treatment, autoimmune diseases, and emergency injections for treating anaphylactic shock and migraine. The global Pen Injectors Market is segmented on the basis of design factors, drug classes, therapeutic sector assessment, type, application, usage and region.
Browse Detail Report With TOC @ http://www.hexareports.com/report/global-pen-injectors-2021
On the basis of design factors, the global market is segmented into Standardized Pen Platforms, Custom Pen Designs, Reusable Pens, Prefilled Pen Cartridges, Disposable Pens, Dual Chamber Pens, Variable vs. Fixed Dosing, and Connected Pens. On the basis of drug classes, the global market is segmented into Antibodies, Anticholinergics, Dopamine Receptors, Hematopoietics, Human Growth Hormone, Immune Modulators, Insulins and Antihyperglycemics, Parathyroid Hormone, Reproductive Hormones, Serotonin Antagonists, and Sympathomimetics.
On the basis of therapeutic assessment, the global market is classified into Anemial, Inflammatory Autoimmune Diseases, Diabetes, Emergency Medicine, Hepatitis, Hormone Replacement, Osteoporosis, Reproductive Health, and the other Commercial Pen Markets & Products. On the basis of type, Insulin Pen Injector holds the largest market share of the global pen injector market. Insulin pen injector is sub segmented into durable and prefilled.
Request A Sample copy of This Report @
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. A durable pen uses a replaceable insulin cartridge. When the insulin cartridge is empty, the empty cartridge is disposed of and a new one is inserted in the pen. A prefilled pen is entirely disposable. The pen comes pre-filled with insulin, and when the insulin cartridge or reservoir is empty, the entire unit is discarded. On the basis of application, the global market is classified into Hospital, Clinic, and others. On the basis of usage, the global market is classified into reusable pen injector and disposable pen injector.
Both the segments account for amajority market share in the global market, with reusable pens enjoying a slightly larger share. It has been noted that disposable pens are preferred in emerging economies such as China and India, while patients in developed countries such as England, Japan, and Germany prefer reusable injection pens. Geographically, the global market is segmented into North America, Europe, China, Japan, India, and Southeast Asia.
North America accounts for the largest market share of pen injector market. Followed by Europe. The U.S. takes the lead of market in North America. This is due to an extensive diabetic population in the country, various technological advancements, surging research and development practices and growing healthcare awareness about the treatment and management of glucose levels.
Asia is projected to exhibit strong growth during the forecast period, with major contribution from countries such as India, Japan, and China. New product launches, favorable regulations, the ability of patients to pay for advanced medical products and devices, and growing awareness levels are likely to drive the market. The key players are Bayer AG, Sanofi, Amedra Pharmaceuticals, ALK Abello, Novartis International AG, Unilife Corporation, Pfizer, Emerade, Ypsomed Holding AG, Sanofi S. A, Biogen Idec, Inc., Emergent BioSolutions, and Owen Mumford.
Browse More Medical Devices Related Market Research Reports:
• Global X-Ray Detectors Market Research Report 2021 –
• Global Surgical Retractor Market Research Report 2016 –
Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe.We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
Email Us: firstname.lastname@example.org
Our Website: http://www.hexareports.com
Visit our Blog: http://hexareports.blogspot.com/